Skip to Main Content
Book cover for Oxford Handbook of Clinical Surgery (4 edn) Oxford Handbook of Clinical Surgery (4 edn)

A newer edition of this book is available.

Close

Contents

Book cover for Oxford Handbook of Clinical Surgery (4 edn) Oxford Handbook of Clinical Surgery (4 edn)
Disclaimer
Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always … More Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Acute abdominal emergencies: overview 426

Acute abdominal pain 302

Acute anorectal pain 414

Acute appendicitis 298

Acute breast pain 248

Acute groin swelling 350

Acute haematemesis 294

Acute limb ischaemia 570

Acute pancreatitis 332

Acute rectal bleeding 416

Acute severe colitis 418

Acute testicular pain 388

Acute upper GI perforation 296

Acute urinary retention (AUR) 386

Acute variceal haemorrhage 330

Burns: assessment 604

Burns: management 606

Cardiac complications 106

Gynaecological causes of lower abdominal pain 306

Haematuria 384

Intra-abdominal abscess 308

Post-operative anastomotic leakage 420

Post-operative haemorrhage 102

Pulmonary embolism 120

Respiratory complications 108

Ruptured abdominal aortic aneurysm 654

Stroke 62

Wound emergencies 104

Common haematology values If outside this range, consult:

Haemoglobin

men:

13–18g/dL

 

women:

11.5–16g/dL

 

Mean cell volume, MCV

76–96fL

 

Platelets

150–400 × 109/L

 

White cells (total)

4–11 × 109/L

 

 Neutrophils

40–75%

 

 Lymphocytes

20–45%

 

 Eosinophils

1–6%

 

Blood gases

kPa

mmHg

 

pH 7.35–7.45

 

PaO2

>10.6

75–100

 

PaCO2

4.7–6

35–45

 

Base excess ±2 mmol/L

 

U&E etc  If outside this range, consult:

 

Sodium

135–145mmol/

 

Potassium

3.5–5mmol/L

 

Creatinine

70–150µmol/L

 

Urea

2.5–6.7mmol/L

 

Calcium

2.12–2.65mmol/L

 

Albumin

35–50g/L

 

Proteins

60–80g/L

 

LFTs

 

Bilirubin

3–17µmol/L

 

Alanine aminotransferase, ALT

3–35U/L

 

Aspartate transaminase, AST

3–35U/L

 

Alkaline phosphatase

30–35U/L (adults)

 

‘Cardiac enzymes’

 

Creatine kinase

25–195U/L

 

Lactate dehydrogenase, LDH

70–250U/L

 

Lipids and other biochemical values

 

Cholesterol

<6mmol/L desired

 

Triglycerides

0.5–1.9mmol/L

 

Amylase

0–180somorgyi U/dL

 

C-reactive protein, CRP

<10mg/L

 

Glucose, fasting

3.5–5.5mmol/L

 

Prostate specific antigen, PSA

0–4ng/mL

 

T4 (total thyroxine)

70–140mmol/L

 

TSH

0.5– ~5mu/L

 

Haemoglobin

men:

13–18g/dL

 

women:

11.5–16g/dL

 

Mean cell volume, MCV

76–96fL

 

Platelets

150–400 × 109/L

 

White cells (total)

4–11 × 109/L

 

 Neutrophils

40–75%

 

 Lymphocytes

20–45%

 

 Eosinophils

1–6%

 

Blood gases

kPa

mmHg

 

pH 7.35–7.45

 

PaO2

>10.6

75–100

 

PaCO2

4.7–6

35–45

 

Base excess ±2 mmol/L

 

U&E etc  If outside this range, consult:

 

Sodium

135–145mmol/

 

Potassium

3.5–5mmol/L

 

Creatinine

70–150µmol/L

 

Urea

2.5–6.7mmol/L

 

Calcium

2.12–2.65mmol/L

 

Albumin

35–50g/L

 

Proteins

60–80g/L

 

LFTs

 

Bilirubin

3–17µmol/L

 

Alanine aminotransferase, ALT

3–35U/L

 

Aspartate transaminase, AST

3–35U/L

 

Alkaline phosphatase

30–35U/L (adults)

 

‘Cardiac enzymes’

 

Creatine kinase

25–195U/L

 

Lactate dehydrogenase, LDH

70–250U/L

 

Lipids and other biochemical values

 

Cholesterol

<6mmol/L desired

 

Triglycerides

0.5–1.9mmol/L

 

Amylase

0–180somorgyi U/dL

 

C-reactive protein, CRP

<10mg/L

 

Glucose, fasting

3.5–5.5mmol/L

 

Prostate specific antigen, PSA

0–4ng/mL

 

T4 (total thyroxine)

70–140mmol/L

 

TSH

0.5– ~5mu/L

 

KleenPrep® 4 sachets over 8h the day preop or CitragMag® 2 sachets over 4h the night preop.

Low risk, e.g. day or fully ambulatory cases: TEDS only.

Medium risk, e.g. major surgery without risk factors or past history of DVT: TEDS + Clexane® 30mg SC od or Fragmin® 2500U SC od.

High risk, e.g. pelvic surgery, malignancy, obesity, past history of DVT: TEDS + Clexane® 30mg SC bd or Fragmin® 5000U SC od.

Minor surgery (e.g. day surgery)

Oral controlled: give normal regimen.

Insulin controlled: omit preop insulin on day of surgery; monitor blood sugar (BS) every 4h; restart normal insulin once oral diet established.

Major surgery

Oral controlled: omit long-acting hypoglycaemics preoperatively; monitor BS every 4h. If BS > 15mmol/L start IV insulin regimen.

Insulin controlled: commence on IV insulin sliding scale preoperatively once NBM and continue until normal diet re-established. Check BS 4-hourly. Restart normal insulin regimen (initially at half dose) once oral diet established.

Typical IV sliding scale (Actrapid® with 5% dextrose):

BS < 4mmol/L: infusion 0.5U/h;

BS 4–15mmol/L, infusion 2.0U/h;

BS 15–20mmol/L, infusion 4.0U/h;

BS > 20mmol/L, infusion 4.0U/h plus consult diabetology team. Con-sider treatment as for ketoacidosis.

Fluid depletion = ((PCV1 – PCV2)/PCV1) × 0.7 × weight in kg

where PCV1 = normal haematocrit and PCV2 = current haematocrit.

Fluid maintenance regimen (correct for age and losses)
Fluid volumeNa+K+ 

100mL/kg for 1st 10kg of weight + 150mL/kg for next 10kg of weight + 20mL/kg for every kg of weight thereafter

2mmol/kg/24h

1mmol/kg/24h

 
Fluid volumeNa+K+ 

100mL/kg for 1st 10kg of weight + 150mL/kg for next 10kg of weight + 20mL/kg for every kg of weight thereafter

2mmol/kg/24h

1mmol/kg/24h

 

Check catheter not blocked.

Check fluid balance status—try bolus crystalloid with frequent reviews.

Check drug chart for possible drug toxicity.

Check fluid balance status first. If in doubt assume it is hypovolaemia.

Check epidural status. Check drug chart for possible drug toxicity.

Each step assumes the previous one has been unsuccessful

Do not interrupt CPR for >10s, except to defibrillate.

Shockable rhythm:

Amiodarone 300mg IV should be given with first dose of adrenaline (peripherally if no central access). A further 150mg may be given, followed by an infusion of 1mg/min for 6h, then 0.5mg/min for 6h.

Alteratives to amiodarone are:

Lidocaine 100mg IV; can repeat once; then give 2–4mg/min IVI.

Procainamide 30mg/min IV to a total dose of 17mg/kg.

Seek expert advice from a cardiologist.

Asystole/PEA2:Give adrenaline 1mg immediately IV access is achieved. Atropine 3mg IV is no longer recommended. If P waves the patient may respond to pacing.

Treat acidosis with good ventilation. Sodium bicarbonate may worsen intracellular acidosis and precipitate arrhythmias, so use only in severe acidosis after prolonged resuscitation (eg 50mL of 8.4% solution by IVI).

Notes
1

Algorithm reproduced with the permission of the Resuscitation Council (UK), ©2010. NB: adrena-line/epinephrine in large doses (eg 5mg) has theoretical haemodynamic advantages, but studies have failed to show benefit (Ballew K 1997 BMJ i 1462). See Baskett P 1992 Br J Anaesthesia 69 182

2

PEA = Pulseless Electrical Activity = electromechanical dissociation (EMD)

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close